article thumbnail

STAT+: House panel expected to mark up pandemic-preparedness bill next week

STAT

WASHINGTON — A House subcommittee will next week mark up a package of public health bills, including pandemic-preparedness legislation, according to five lobbyists. The House Energy & Commerce Committee hasn’t yet announced the markup, and the lobbyists didn’t know the exact date.

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake. References.

Dosage 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

It is too early to say because we have not seen the whole package of measures yet. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. The cost of opportunity – A study on pharmaceutical R&D costs [Internet].

article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023.

Packaging 117
article thumbnail

Solving the taxing problems of taxanes?

European Pharmaceutical Review

6 In March 2021, following a pre-NDA meeting, the company issued a release stating “[the company] has concluded that the clinical data package for Tesetaxel is unlikely to support FDA approval”, and the programme was subsequently terminated. 2006 [cited 7 September 2022];17(5):735-749. References. Hennenfent K, Govindan R.

article thumbnail

Sudafed Dosage, Uses, and Side Effects

BuzzRx

Keeping Sudafed products behind the counter, along with other regulations, was mandated by the FDA in 2006 because pseudoephedrine, the main ingredient in Sudafed products, can be used illegally to make methamphetamine. Read the package label carefully to check the right product and dosage for your child. Is Sudafed OK to take daily?

Dosage 52
article thumbnail

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic

Pharmaceutical Technology

Study designs can be conventional, hybrid, or tracer studies, which can all generate the required data and be suitable to form part of the eventual regulatory submission data package. Since 2006, Quotient Sciences has provided radiolabeled clinical research for the pharmaceutical industry at our Nottingham, UK, site.